DIMMITROL HEARTWORM TABLET 400MG

Riik: Austraalia

keel: inglise

Allikas: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Toimeaine:

DIETHYLCARBAMAZINE CITRATE

Saadav alates:

MAVLAB PTY. LTD.

INN (Rahvusvaheline Nimetus):

diethylcarbamazine citrate(400mg/Tb)

Ravimvorm:

ORAL TABLET

Koostis:

DIETHYLCARBAMAZINE CITRATE CARBAMATE-ETHYLCARBAMATE Active 400.0 mg/Tb

Ühikuid pakis:

100 Tabs; 1000 Tabs

Klass:

VM - Veterinary Medicine

Terapeutiline rühm:

DOG | BITCH | CASTRATE | PUPPY

Terapeutiline ala:

PARASITICIDES

Näidustused:

HEARTWORM - PREVENTION OF | TO PREVENT HEARTWORM

Toote kokkuvõte:

Poison schedule: 0; Withholding period: WHP: N/A; Host/pest details: DOG: [HEARTWORM - PREVENTION OF]; Poison schedule: 0; Withholding period: ; Host/pest details: DOG: [HEARTWORM - PREVENTION OF]; For the prevention of heartworm disease in dogs.Adverse reactions might occur in administering this product to dogs with heartworm. Consult your veterinarian before the initial administration.

Volitamisolek:

Registered

Loa andmise kuupäev:

2023-07-01

Infovoldik

FOR ANIMAL TREATMENT
ONLY
Mavlab logo
We Do Care
33 Rowland St.,
Slacks Creek, Qld 4127
DIMMITROL
HEARTWORM
TABLET
400 mg
For the prevention
of
heartworm disease_ (Dirofilaria_
_immitis)_ in dogs.
DIRECTIONS FOR USE:
Administer daily to dogs at the rate
of
5.5 mglkg
bodyweight (BW) or
Weight
(kg)
Tablets
per
day
5-18
1/4
19-36
1/2
37-72
1
WARNING:
Administer to dogs
free
ofmicrofi1ariae.
Consult a veterinarian before use.
Adverse reactions
may occur when administering this product to dogs for
prevention
of
heartworm
STORAGE:
Store below 30°C.
(Room
Temperature).
Replace lid tightly after use.
DISPOSAL:
Dispose
of
empty container
by
wrapping
in paper
a~d
lacing in garbage.
J
7'13/
_o')o(_
NRA Ap
oval No.
Expiry
Batch No.
2460/94/A
HH1394
100 TABLETS
ACTIVE CONSTITUENT:
Each tablet contains 400
mg DIETHYLCARBAMAZINE CITRATE
(equivalent to 203.7 mg DIETHYLCARBAMAZINE)
NET CONTENTS:
FOR ANIMAL TREATMENT
ONLY
Mavlab logo
We Do Care
33 Rowland St.,
Slacks Creek,
Qld 4127
For the prevention
of
heartworm disease_ (Dirofilaria_
_immilis)_ in dogs.
DlMMITROL
HEARTWORM
TABLET
400mg
DIRECTIONS FOR USE:
Administer daily to dogs at the rate
of5.5
mgIkg
bodyweight (BW) or
Weight
(kg)
Tablets
per
day
5-18
1/4
19-36
1/2
31-72
1
WARNING:
Administer to dogs free
of
microfilariae.
Consult a veterinarian before use.
Adverse reactions
may occur when administering this product to dogs for
prevention
of
heartworm
STORAGE:
Store below 30°C.
(Room
Temperature).
Replace lid tightly after use.
DISPOSAL:
Dispose
of
empty container by wrapping
in paper
a~d
lacing in garbage.
_17'1_
7, /
c).
<>/
NRA Ap
oval No.
Expiry
Batch No.
2460/94/A
HH1394
1000 TABLETS
ACTIVE CONSTITUENT:
Each tablet contains 400
mg DIETHYLCARBAMAZINE CITRATE
(equivalent to 203.7 mg DIETHYLCARBAMAZINE)
NET CONTENTS:
. NoR.A.
,
APPROVED
LABEL
(TEXT)
Label
No:
..
~J.~.~.I./Q.~.9.L...
Date:
...
,*.~.1
_..._
~
_..._
.1.~~.l..
Signature:
~.:B.C}~rJ.l..~

Toote omadused

MAVLAB PTY LTD
Date of Issue:
October 2007
MATERIAL SAFETY DATA SHEET
DIMMITROL HEARTWORM TABLETS 400 mg
Page 1 of 4
MSDS version:
3
Date of Revision:
October, 2007
Update of section:
All sections
SECTION 1 IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Product (material) name:
Dimmitrol Heartworm Tablets 400 mg
Other names:
Manufacturer's Code: P2560, P2580
Recommended use:
Prevention of heartworm (
_Dirofilaria immitis_
) in dogs
Supplier Details:
Mavlab Pty Ltd ACN 068 507 148
33 Rowland Street
SLACKS CREEK QLD 4127
Contact Person:
Dr Paul Ross
Emergency Telephone:
[phone]
Facsimile:
[phone]
SECTION 2 HAZARDS IDENTIFICATION
This product is classified as dangerous goods under the Australian
Dangerous Goods Code and hazardous according
to the classification criteria of NOHSC:1008(2004), Approved Criteria
For Classifying Hazardous Substances and
the National Code of Practice for the Preparation of Material Safety
Data Sheets 2
nd
Edition [NOHSC:2011(2003)].
The following risk and safety phrases apply to diethylcarbamazine
citrate (DECC), the active constituent in these
tablets. The percentage of DECC in the tablets is above the
concentration cut-off that would enable the product to be
considered as not hazardous.
Risk phrases:
R21/22:
Harmful in contact with skin and if swallowed.
R26:
Toxic by inhalation.
R36/37/38:
Irritating to eye, to respiratory system and skin.
Safety phrases:
S22:
Do not breathe dust.
S24/25:
Avoid contact with skin and eyes.
S26:
In case of contact with eyes, rinse immediately with plenty of water
and seek medical
advice.
S28:
After contact with skin, wash immediately with plenty of water.
S62:
If swallowed, do not induce vomiting, seek medical advice immediately
and show this
container label.
S36/37/39:
Wear suitable protective clothing, gloves and eye/face protection. In
case of accident or if
you feel unwell seek medical advice immediately.
S38:
In case of insufficient ventilation, wear suitable respiratory
equipment.
SECTION 3 COMPOSITION/INFORMATION ON INGREDIENTS
Ingredie